A novel hypoxia-driven gene signature that can predict the prognosis and drug resistance of gliomas
Published 2022 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
A novel hypoxia-driven gene signature that can predict the prognosis and drug resistance of gliomas
Authors
Keywords
-
Journal
Frontiers in Genetics
Volume 13, Issue -, Pages -
Publisher
Frontiers Media SA
Online
2022-09-02
DOI
10.3389/fgene.2022.976356
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- HIF-1α stimulates the progression of oesophageal squamous cell carcinoma by activating the Wnt/β-catenin signalling pathway
- (2022) Kang Tang et al. BRITISH JOURNAL OF CANCER
- Surgical Neuro-Oncology
- (2022) Dana Mitchell et al. NEUROLOGIC CLINICS
- Recent advances in glioma microenvironment-response nanoplatforms for phototherapy and sonotherapy
- (2022) Xuemeng Li et al. PHARMACOLOGICAL RESEARCH
- Inhibition of translocator protein 18 kDa suppressed the progression of glioma via the ELAV-like RNA-binding protein 1/MAPK-activated protein kinase 3 axis
- (2022) Jingya Wang et al. Bioengineered
- Therapeutic Targeting Hypoxia-Inducible Factor (HIF-1) in Cancer: Cutting Gordian Knot of Cancer Cell Metabolism
- (2022) Abhilasha Sharma et al. Frontiers in Genetics
- The Many Facets of Therapy Resistance and Tumor Recurrence in Glioblastoma
- (2021) Anshika Goenka et al. Cells
- oncoPredict: an R package for predicting in vivo or cancer patient drug response and biomarkers from cell line screening data
- (2021) Danielle Maeser et al. BRIEFINGS IN BIOINFORMATICS
- NBM-BMX, an HDAC8 Inhibitor, Overcomes Temozolomide Resistance in Glioblastoma Multiforme by Downregulating the β-Catenin/c-Myc/SOX2 Pathway and Upregulating p53-Mediated MGMT Inhibition
- (2021) Cheng-Yu Tsai et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- SHOX2 cooperates with STAT3 to promote breast cancer metastasis through the transcriptional activation of WASF3
- (2021) Yong Teng et al. JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH
- The relationship between expression of PD-L1 and HIF-1α in glioma cells under hypoxia
- (2021) Xing-chen Ding et al. Journal of Hematology & Oncology
- Hypoxia, Metabolic Reprogramming, and Drug Resistance in Liver Cancer
- (2021) Macus Hao-Ran Bao et al. Cells
- Hypoxia‐inducible lncRNA MIR210HG interacting with OCT1 is involved in glioblastoma multiforme malignancy
- (2021) Kuo‐Hao Ho et al. CANCER SCIENCE
- HOXC6/8/10/13 predict poor prognosis and associate with immune infiltrations in glioblastoma
- (2021) Mingjun Yu et al. INTERNATIONAL IMMUNOPHARMACOLOGY
- Carrier-free nanoparticles of camptothecin prodrug for chemo-photothermal therapy: the making, in vitro and in vivo testing
- (2021) Mingtao Ao et al. JOURNAL OF NANOBIOTECHNOLOGY
- A Hypoxia-Associated Prognostic Gene Signature Risk Model and Prognosis Predictors in Gliomas
- (2021) Feng Gao et al. Frontiers in Oncology
- Elevated MMP9 expression in breast cancer is a predictor of shorter patient survival
- (2020) Chitra Joseph et al. BREAST CANCER RESEARCH AND TREATMENT
- Hypoxia induced ferritin light chain (FTL) promoted epithelia mesenchymal transition and chemoresistance of glioma
- (2020) Junhui Liu et al. JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH
- MGMT genomic rearrangements contribute to chemotherapy resistance in gliomas
- (2020) Barbara Oldrini et al. Nature Communications
- Molecular landmarks of tumor hypoxia across cancer types
- (2019) Vinayak Bhandari et al. NATURE GENETICS
- Seven genes for the prognostic prediction in patients with glioma
- (2019) G.-H. Zhang et al. Clinical & Translational Oncology
- MyoD1 suppresses cell migration and invasion by inhibiting FUT4 transcription in human gastric cancer cells
- (2019) Fei Wu et al. CANCER GENE THERAPY
- In vivo assessment of reactive oxygen species production and oxidative stress effects induced by chronic exposure to gamma radiation in Caenorhabditis elegans
- (2019) Erica Maremonti et al. FREE RADICAL BIOLOGY AND MEDICINE
- Temozolomide for immunomodulation in the treatment of glioblastoma
- (2018) Aida Karachi et al. NEURO-ONCOLOGY
- Overcoming therapeutic resistance in glioblastoma: the way forward
- (2017) Satoru Osuka et al. JOURNAL OF CLINICAL INVESTIGATION
- MicroRNA-145 induces apoptosis of glioma cells by targeting BNIP3 and Notch signaling
- (2017) Yan Du et al. Oncotarget
- Downregulation of HIF-1a sensitizes U251 glioma cells to the temozolomide (TMZ) treatment
- (2016) Jun-Hai Tang et al. EXPERIMENTAL CELL RESEARCH
- Deletions of 5′HOXCgenes are associated with lower extremity malformations, including clubfoot and vertical talus
- (2016) David M Alvarado et al. JOURNAL OF MEDICAL GENETICS
- Neuromuscular electrical stimulation improves radiation-induced fibrosis through Tgf-Β1/MyoD homeostasis in head and neck cancer
- (2016) Grace Peng et al. JOURNAL OF SURGICAL ONCOLOGY
- SHOX2 is a Potent Independent Biomarker to Predict Survival of WHO Grade II–III Diffuse Gliomas
- (2016) Yu-An Zhang et al. EBioMedicine
- Mutations of p53 and KRAS activate NF-κB to promote chemoresistance and tumorigenesis via dysregulation of cell cycle and suppression of apoptosis in lung cancer cells
- (2015) Lina Yang et al. CANCER LETTERS
- Tumor cell-produced matrix metalloproteinase 9 (MMP-9) drives malignant progression and metastasis of basal-like triple negative breast cancer
- (2015) Christine Mehner et al. Oncotarget
- MGMT testing—the challenges for biomarker-based glioma treatment
- (2014) Wolfgang Wick et al. Nature Reviews Neurology
- Bortezomib overcomes MGMT-related resistance of glioblastoma cell lines to temozolomide in a schedule-dependent manner
- (2013) Panagiotis J. Vlachostergios et al. INVESTIGATIONAL NEW DRUGS
- Hypoxia and hypoxia-inducible factors in glioblastoma multiforme progression and therapeutic implications
- (2012) Liuqi Yang et al. EXPERIMENTAL CELL RESEARCH
- SHOX2 DNA Methylation Is a Biomarker for the Diagnosis of Lung Cancer in Plasma
- (2011) Christoph Kneip et al. Journal of Thoracic Oncology
- Hypoxia Helps Glioma to Fight Therapy
- (2009) Verena Amberger-Murphy CURRENT CANCER DRUG TARGETS
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreFind the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
Search